Figures & data
Table 1 Outcome measures at Week 17 of PP1M treatment based on 6-month remission status to PP3M
Figure 1 Predicted probabilities of remission using the univariate model for each significant predictor of remission: (A) PANSS Marder negative symptom factor, (B) CGI-S, and (C) PSP total score.a
Abbreviations: CGI-S, Clinical Global Impression-Severity; PANSS, Positive and Negative Syndrome Scale; PSP, Personal and Social Performance.
![Figure 1 Predicted probabilities of remission using the univariate model for each significant predictor of remission: (A) PANSS Marder negative symptom factor, (B) CGI-S, and (C) PSP total score.a](/cms/asset/cd37a709-dac5-4799-a7cd-83d61b7bbbde/dndt_a_194264_f0001_b.jpg)
Table 2 Univariate logistic regression model of predictors of 6-month remission
Figure 2 Variables predicting achievement of remission with PP3M during the double-blind treatment phase (multivariate analyses).
Abbreviations: CGI-S, Clinical Global Impression-Severity; PANSS, Positive and Negative Syndrome Scale; PP3M, paliperidone palmitate 3-month formulation; PSP, Personal and Social Performance.
![Figure 2 Variables predicting achievement of remission with PP3M during the double-blind treatment phase (multivariate analyses).](/cms/asset/ec0fc809-3748-43fb-86fc-d9a74bb775a8/dndt_a_194264_f0002_b.jpg)
Table 3 Multivariate logistic regression model of predictors of 6-month remission